Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PKNOX2 | hg38_v1_chr11_+_125164709_125164741 | 0.60 | 3.3e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_210315160 Show fit | 4.80 |
ENST00000352451.4
|
myosin light chain 1 |
|
chr19_-_45322867 Show fit | 3.31 |
ENST00000221476.4
|
creatine kinase, M-type |
|
chr1_-_201112420 Show fit | 2.57 |
ENST00000362061.4
ENST00000681874.1 |
calcium voltage-gated channel subunit alpha1 S |
|
chr2_-_178807415 Show fit | 2.51 |
ENST00000342992.10
ENST00000460472.6 ENST00000589042.5 ENST00000591111.5 ENST00000360870.10 |
titin |
|
chr6_+_41053194 Show fit | 2.41 |
ENST00000244669.3
|
apolipoprotein B mRNA editing enzyme catalytic subunit 2 |
|
chr5_+_79689825 Show fit | 2.28 |
ENST00000446378.3
|
cardiomyopathy associated 5 |
|
chr8_-_74321532 Show fit | 2.10 |
ENST00000342232.5
|
junctophilin 1 |
|
chr1_-_201112451 Show fit | 2.07 |
ENST00000367338.7
|
calcium voltage-gated channel subunit alpha1 S |
|
chr9_-_83817632 Show fit | 1.59 |
ENST00000376365.7
ENST00000376371.7 |
G kinase anchoring protein 1 |
|
chr15_-_61229155 Show fit | 1.40 |
ENST00000558904.2
|
RAR related orphan receptor A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.8 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.3 | 4.6 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.2 | 3.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 2.6 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.3 | 2.5 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.2 | 2.4 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 2.4 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 1.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 1.1 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 0.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 4.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 2.3 | GO:0031430 | M band(GO:0031430) |
0.1 | 2.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 1.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 1.6 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 1.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 6.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 5.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 3.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 3.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 2.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 2.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.8 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 2.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 4.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 3.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 2.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 1.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 1.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |